Company intelligence / Profile preview

Emerald Advisers

Lancaster, Pennsylvania, USAteamemerald.com ↗

Ownership: Private
Development stage: Other

Overview

Emerald Advisers is a U.S.-based asset management firm focused on active, research-driven investment strategies. It specializes in small and mid-cap growth equities and has recently expanded into the life sciences sector through the launch of the F/m Emerald Life Sciences Innovation ETF (LFSC), which invests in innovative biotech, healthcare, and medical device companies. The firm leverages proprietary research to identify high-potential companies at early stages of innovation.

Industry: Investors

Partnerships

F/m Investments – co-sponsor/sub-advisor for LFSC ETFRBB Fund Complex – operational partner for fund distribution

Beyond the preview

Go deeper on Emerald Advisers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emerald Advisers.

Explore the full profile